United States · FDA National Drug Code directory
Rowasa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0037-0066_8c9b1d5d-7391-4bf0-b0d5-079c5c45526f
- Product NDC
- 0037-0066
- Form
- SUSPENSION
- Composition / generic term
- mesalamine
- Labeler
- Viatris Specialty LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160324
- Source listing expiry
- 20271231
Source-listed ingredients
- MESALAMINE — 4 g/60mL
These values do not establish equivalence or a dose recommendation.
Packages
- 28 BOTTLE, DISPENSING in 1 CARTON (0037-0066-03) / 60 mL in 1 BOTTLE, DISPENSING (0037-0066-06) · 0037-0066-03
- 7 BOTTLE, DISPENSING in 1 CARTON (0037-0066-05) / 60 mL in 1 BOTTLE, DISPENSING (0037-0066-06) · 0037-0066-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →